Taxotere Hair Loss Lawsuit
A Taxotere hair loss lawsuit may be an option for patients who suffered from permanent hair loss after taking the drug as a part of their chemotherapy treatment for certain forms of cancer. Specifically, lawsuits allege that women who were treated with the drug for breast cancer experienced disfiguring permanent hair loss. Affected patients and their families may be eligible to pursue a claim and seek compensation with the help of a bad drugs attorney.
For more information, contact Attorney Group today. Our consultations are free, confidential and without any obligation on your part. We can help answer your questions, and if you choose to pursue a claim we can connect you with an affiliated Taxotere hair loss lawsuit attorney who can assist you throughout the legal process.
Have You Seen a Taxotere Hair Loss Lawsuit Commercial?
You may have seen a Taxotere hair loss lawsuit commercial on television and wondered whether you or a loved one have been affected by Taxotere and, if so, whether you are eligible to pursue a claim against the manufacturer or others. The purpose of this article is to provide you with additional information so that you have a better understanding of your options.
What is Taxotere?
Taxotere is a form of chemotherapy used in the treatment of various forms of cancer, including breast, lung, prostate, stomach, and head and neck cancer. Taxotere is a part of a family of drugs commonly referred to as taxanes, chemical compounds produced by the plants of the genus Taxus (yew trees). Taxotere, like other types of cancer treatments, fights cancer by preventing cancer cells from growing. The treatment was approved by the U.S. Food and Drug Administration (FDA) in 1996 and is developed, manufactured and distributed by Sanofi-Aventis and its related companies.
What are the Risks of Taxotere?
Taxotere Side Effects include:
- Extreme weakness
- Severe vomiting or diarrhea
- Fever, chills, body aches
- Easy bruising
- Rapid heart rate
- Trouble concentrating
Serious side effects associated with Taxotere may include:
- Permanent hair loss (alopecia)
- Heart issues
- Nerve damage
- Alcohol intoxication
- Eye disorders
- Allergic reactions
A Taxotere hair loss lawsuit may be an option for patients who suffered permanent hair loss or other side serious side effects as a result of the drug.
Attorney Group 2226 Cottondale Ln, #200 Little Rock AR 72202 (888) 888-0612These guys are a pleasure to work with -- very strategic and very responsive, which makes for a great business partner! I can tell that they are passionate about making sure all clients get the attention and expertise they deserve.Passionate About Clients Lauren A. 5
Taxotere and Permanent Hair Loss
Although temporary hair loss may be a possible side effect of chemotherapy or radiation therapy, complete and permanent hair loss (alopecia) is not and has been linked to Taxotere. In December 2015, the FDA updated the warning label for Taxotere to include the risk of permanent hair loss associated with the drug.
Additionally, a study carried out on 20 women who had breast cancer chemotherapy and had taken Taxotere, found that no regrowth of the scalp was noted. The research, conducted between 2007 and 2011, even involved regrowth treatments including vitamins and ultraviolet A therapy, but still no hair regrowth was observed. Another study, published in the 2011 American Journal of Dermatopathology found that “there is increased evidence that certain chemotherapy regimens can cause dose-dependent permanent alopecia”, including Taxotere for breast cancer.
Taxotere Hair Loss Lawsuit Claims
Lawsuits allege that, despite the assertions of the drug maker, Taxotere does not have superior efficacy to other drugs containing Taxanes, such as Taxol. Plaintiffs claim that the drug makers concealed from the FDA, from doctors, and from patients the existence of a study concluding that Taxol was, in fact, more effective than Taxotere for certain chemotherapy patients. Additionally, plaintiffs claim that the drug makers engaged in “a fraudulent marketing scheme, paying kickbacks, and providing other unlawful incentives to entice physicians to use” Taxotere.
The drug makers are accused in lawsuits of misleading the public and the medical community to believe that, like other chemotherapy drugs, patients who took Taxotere would see their hair grow back.
Affected patients claim that the permanent hair loss they suffered as a result of taking Taxotere caused them to experience a “disfiguring condition,” resulting in mental anguish and economic damages.
According to a Taxotere hair loss lawsuit, plaintiffs claim that:
Although women might accept the possibility of permanent baldness as a result of the use of Taxotere if no other product were available to treat their cancer, this was not the case. Before Defendants’ wrongful conduct resulted in thousands of women being exposed to the side effects of Taxotere, there were already similar products on the market that were at least as effective as Taxotere and did not subject female users to the same risk of disfiguring permanent alopecia as does Taxotere.
Has There Been a Taxotere Recall?
As of January 2017, there has not been a Taxotere recall relating to alopecia or permanent hair loss. It was not until December 2015 that the FDA warned that Taxotere may result in permanent hair loss and updated the warning label for the drug.
Although there has not been a Taxotere recall, potential lawsuits may claim that the drug makers failed to disclose known side effects of the drug and that patients suffered damages as a result. Failure to warn of side effects of a drug can be a basis of drug company liability, regardless of whether the drug has been recalled.
Is There a Taxotere Class Action?
There is no Taxotere class action pending as of January 2017. Taxotere hair loss lawsuit attorneys are doubtful that a class action will be certified for patients who are adversely affected by the drug. Instead, if multiple Taxotere hair loss lawsuit claims are filed against the drug makers alleging injuries and other damages caused by Taxotere and similar drugs, it is anticipated that these lawsuits will be consolidated for discovery and other pretrial proceedings.
When cases are consolidated in this way in federal court it is called multidistrict litigation (MDL), and on a state level it is known as a state court consolidated proceeding. MDLs are distinct from class actions, and it is generally agreed that consolidating cases instead of proceeding in a class action is a more efficient and effective way of handling claims arising from injuries caused by pharmaceutical products.
Has There Been Taxotere Settlements?
Some cases settle early in the claims process, but it is not expected that there will be early Taxotere settlements. In most cases that proceed in an MDL or state court consolidated proceedings, after a certain period of time initial trials, also known as bellwether trials, take place. The purpose of these trials is for the parties to get an idea of the types of evidence and arguments that will made, as well as to see how juries will respond to the evidence and arguments. After a certain number of cases have been tried, the parties are in a better position to determine whether a case can be settled.
It is expected that Taxotere settlements will follow this pattern, although the outcome of any case is never guaranteed and past results are not necessarily predictive of future outcomes.
Taxotere Hair Loss Lawsuit News
- December 2016According to a pretrial order issued by the U.S. District Judge appointed to oversee hearings in Louisiana, the judge granted direct filing of new cases into already established MDL to avoid delays and allow for discovery and additional pretrial screenings.
- November 2016Taxotere lawsuit filed claiming that the plaintiff experienced permanent hair loss, and continued to experience hair loss, after having been treated with Taxotere.
- October 2016Over 30 Taxotere hair loss lawsuits are consolidated and centralized in the U.S. District Court for the Eastern District of Louisiana involving cases alleging that Sanofi-Aventis failed to adequately warn patients of the risk of permanent hair loss associated with the chemotherapy treatment.
- September 2016Taxotere hair loss lawsuit claims that Sanofi-Aventis knew or should have known that the chemotherapy treatment was associated with an increased risk of permanent hair loss.
- December 2015The FDA updated the warning label for Taxotere to include the risk of permanent hair loss associated with the drug.
How a Taxotere Hair Loss Lawsuit Can Help
Drug makers have a duty to provide safe products. If there are risks of harm associated with their products, they also must provide adequate warnings. If a drug maker fails to fulfill this duty, it could be held liable in lawsuits for injuries that may result.
Patients who have been injured by Taxotere may be eligible to recover money for:
- Medical Expenses
- Lost Wages
- Pain and Suffering
The families of those who have died may be eligible to recover money for funeral expenses and the pain that comes with losing a loved one.